ReviewExpert opinion on investigational drugs2017

Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia.

Hima V Vangapandu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.